Literature DB >> 35963365

Durability of Immunity Is Low Against Severe Acute Respiratory Syndrome Coronavirus 2 Omicron BA.1, BA.2, and BA.3 Variants After Second and Third Vaccinations in Children and Young Adults With Inflammatory Bowel Disease Receiving Biologics.

Lorenza Bellusci1, Fatema Tuz Zahra1, Dena E Hopkins2, Juan C Salazar2, Jeffrey S Hyams2, Surender Khurana3.   

Abstract

Entities:  

Year:  2022        PMID: 35963365      PMCID: PMC9364917          DOI: 10.1053/j.gastro.2022.08.009

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   33.883


× No keyword cloud information.
  6 in total

1.  Why does the Omicron sub-variant spread faster than the original?

Authors:  Ewen Callaway
Journal:  Nature       Date:  2022-02       Impact factor: 49.962

2.  Antibody Responses to SARS-CoV-2 After Infection or Vaccination in Children and Young Adults With Inflammatory Bowel Disease.

Authors:  Joelynn Dailey; Lina Kozhaya; Mikail Dogan; Dena Hopkins; Blaine Lapin; Katherine Herbst; Michael Brimacombe; Kristen Grandonico; Fatih Karabacak; John Schreiber; Bruce Tsan-Liang Liang; Juan C Salazar; Derya Unutmaz; Jeffrey S Hyams
Journal:  Inflamm Bowel Dis       Date:  2022-07-01       Impact factor: 7.290

3.  Cross-reactive immunity against the SARS-CoV-2 Omicron variant is low in pediatric patients with prior COVID-19 or MIS-C.

Authors:  Juanjie Tang; Tanya Novak; Julian Hecker; Gabrielle Grubbs; Fatema Tuz Zahra; Lorenza Bellusci; Sara Pourhashemi; Janet Chou; Kristin Moffitt; Natasha B Halasa; Stephanie P Schwartz; Tracie C Walker; Keiko M Tarquinio; Matt S Zinter; Mary A Staat; Shira J Gertz; Natalie Z Cvijanovich; Jennifer E Schuster; Laura L Loftis; Bria M Coates; Elizabeth H Mack; Katherine Irby; Julie C Fitzgerald; Courtney M Rowan; Michele Kong; Heidi R Flori; Aline B Maddux; Steven L Shein; Hillary Crandall; Janet R Hume; Charlotte V Hobbs; Adriana H Tremoulet; Chisato Shimizu; Jane C Burns; Sabrina R Chen; Hye Kyung Moon; Christoph Lange; Adrienne G Randolph; Surender Khurana
Journal:  Nat Commun       Date:  2022-05-27       Impact factor: 17.694

4.  Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection.

Authors:  David S Khoury; Deborah Cromer; Arnold Reynaldi; Timothy E Schlub; Adam K Wheatley; Jennifer A Juno; Kanta Subbarao; Stephen J Kent; James A Triccas; Miles P Davenport
Journal:  Nat Med       Date:  2021-05-17       Impact factor: 87.241

5.  Neutralization of SARS-CoV-2 Omicron and other variants in serum from children with vaccination-induced myocarditis.

Authors:  Fatema Tuz Zahra; Gabrielle Grubbs; Kirsten Dummer; Adriana H Tremoulet; Chisato Shimizu; Jane C Burns; Surender Khurana
Journal:  Clin Infect Dis       Date:  2022-04-21       Impact factor: 9.079

Review 6.  Effectiveness and Durability of COVID-19 Vaccination in 9447 Patients With IBD: A Systematic Review and Meta-Analysis.

Authors:  Anuraag Jena; Deepak James; Anupam K Singh; Usha Dutta; Shaji Sebastian; Vishal Sharma
Journal:  Clin Gastroenterol Hepatol       Date:  2022-02-19       Impact factor: 13.576

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.